Global Protein Stain Market Anticipated to Reach USD 219.83 Million by 2032

According to a recent market study published by Growth Market Reports, titled, “Global Protein Stain Market is segmented into by type, by application, by end-user and by region: Size, Share, Trends and Opportunity Analysis, 2017-2032”, the market was valued at USD 119.09 Million in 2023 and is expected to grow at a growth rate of 7.3% by the year 2032.

Protein stains are specialized dyes or ligands employed to visualize proteins separated by techniques such as gel electrophoresis. The post-separation visualization allows for the analysis of protein size, quantity, and distribution within the gel matrix. Protein staining is an essential step in protein analysis, enabling researchers to visualize, quantify, and characterize proteins separated by gel electrophoresis. Researchers gain valuable insights into protein expression, localization, and function within biological systems by selecting the appropriate staining method.

Get Sample Report @ https://growthmarketreports.com/request-sample/6670

On the basis of type, the protein stain market is segmented into protein staining device and reagents (stain type). The reagents (stain type) segment is further subdivided into coomassie stains, silver stains, fluorescent stains, and stain-free technology. The Reagents (stain type) segment is anticipated to hold significant market share in the 2023, as reagents provide a sensitive, environmentally friendly, and efficient protein staining solution.

Based on by application, the protein stain market is classified as protein separation, protein analysis, and others. The protein separation segment is anticipated to hold a substantial share of the market in 2023, as protein staining is an essential tool in protein separation techniques, enabling researchers to visualize, quantify, and characterize proteins.

In terms of end-user, the protein stain market is segmented into biotechnology & pharmaceutical companies, academic & research institutes, contract research organizations, and others. The biotechnology & pharmaceutical companies segment is expected to dominate the market during the forecast period, as protein stains are widely used in protein-drug interactions study. The academic & research institutes segment held a large market share in 2022 and is anticipated to grow at a rapid pace during the forecast period, as protein stains provides valuable insights into protein structure, function, and expression in life science study.

The outbreak of Coronavirus disease in 2019 (COVID-19) had a negative impact on the global Protein Stain market. Lockdowns and social distancing measures led to the closure of some research labs or reduced staffing, impacting research activities that rely on protein stains. Many research labs shifted their focus on studying the SARS-CoV-2 virus and developing vaccines and therapeutics, leading to a temporary decline in demand for protein stains used in other research areas. Disruptions in transportation networks and border closures caused delays in the delivery of raw materials and finished protein stains, impacting research timelines and workflows.

As per growth market reports by industry analyst Anuradha More, “Increasing application of stains in diagnostics and increasing research and development in life sciences are expected to increase the usage of protein stain.”

Supply chain management is an essential part of any business. A supply chain contains a series of steps to get products from their original state to the customers. Raw materials used for manufacturing Protein Stain are shipped to manufacturers to process into final products. Quality checks are performed throughout the production process by manufacturers to ensure the quality of the product.

Key Takeaways from the Study:

The players in the Global Protein Stain market include Abbkine, Inc.; ApexBio Technology; Bio-Rad Laboratories, Inc.; Bio-Techne (Tocris Bioscience); Biotium; Bulldog-Bio; FUJIFILM Holdings Corporation; GenScript; LI-COR Biotech, LLC; LOBA CHEMIE PVT. LTD.; MBL International Corporation (MBLI); Merck KGaA; Orochem Technologies Inc.; Sangon Biotech (Shanghai) Co., Ltd. (BBI Life Sciences); and Thermo Fisher Scientific Inc.

Target Audience:

• Supply-side: Manufacturer and distributors.

• Demand Side: Biotechnology & Pharmaceutical Companies, Academic & Research Institutes, Contract Research Organizations, and others

• Regulatory Side: Approved regulatory bodies.

• Associations and Industry Bodies: Food and Drug Administration (FDA), European Medicines Agency (EMA), World Health Organization (WHO), and others.